DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹82.68 | ₹60.38 | ₹68.83 | ₹111.53 | ₹74.75 |
What is the latest Earnings Per Share (EPS) of DIVIS LABORATORIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹82.68 |
| Mar2025 | ₹60.38 |
| Mar2024 | ₹68.83 |
| Mar2023 | ₹111.53 |
| Mar2022 | ₹74.75 |
How is Earnings Per Share (EPS) of DIVIS LABORATORIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹82.68 | 36.93 | |
| Mar2025 | ₹60.38 | -12.28 | |
| Mar2024 | ₹68.83 | -38.29 | |
| Mar2023 | ₹111.53 | 49.20 | |
| Mar2022 | ₹74.75 | - | |
Compare Earnings Per Share (EPS) of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹240,277.5 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| MANKIND PHARMA | ₹99,821.1 Cr | 0.3% | -8.6% | -5.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 5% |
21.5% |
44.5% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses